MedTrace Logo

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia

NCT02468323 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-03-09

No results posted yet for this study

Summary

This study aims to compare the quality of perioperative antiemesis of palonosetron and ondansetron in patients undergoing cesarean section

Conditions

  • PONV

Interventions

DRUG

Placebo

Patients will receive regular spinal anesthesia

DRUG

Ondansetron

Patients will receive slow intravenous injection of ondansetron 4 mg after cord clamping

DRUG

Palonosetron

Patients will receive slow intravenous infection of palonosetron 75 mcg after cord clamping

Sponsors & Collaborators

  • Hospital de Base

    lead OTHER

Principal Investigators

  • Fabricio T Mendonca, MD, TSA · Hospital de Base do Distrito Federal

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02468323 on ClinicalTrials.gov